← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 25, 2019Last known activity
Nov 10, 2025
Timeline
2000s
- Jun 1, 2002
Staidson (Beijing) Biopharmaceuticals Co., Ltd— Founded
Drugs by trial phase (12 distinct, 27 trials)
Phase 3 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (27)
- NCT07168161Lead sponsorPhase 3Nov 10, 2025
- NCT07208591Lead sponsorPhase 3Oct 31, 2025
- NCT06975748Lead sponsorPhase 2Jun 12, 2025
- NCT06948799Lead sponsorPhase 1May 8, 2025
- NCT06597422Lead sponsorPhase 1Oct 31, 2024
- NCT06563713Lead sponsorPhase 1Jul 31, 2024
- NCT06289166Lead sponsorPhase 2Mar 18, 2024
- NCT06038916Lead sponsorPhase 1/Phase 2Dec 9, 2023
- NCT06148389Lead sponsorPhase 1Nov 21, 2023
- NCT05986877Lead sponsorPhase 1Aug 7, 2023
- NCT05760703Lead sponsorPhase 2Apr 25, 2023
- NCT05760781Lead sponsorPhase 2Apr 25, 2023
- NCT05702983Lead sponsorPhase 1Jan 31, 2023
- NCT05619926Lead sponsorPhase 2Dec 31, 2022
- NCT05559125Lead sponsorPhase 1Nov 8, 2022
Details
- Founded
- Beijing, CN Jun 1, 2002
- Last known activity
- Nov 10, 2025